Spatiotemporal Metabolomic Approaches to the Cancer-immunity Panorama: a Methodological Perspective
Overview
Oncology
Authors
Affiliations
Metabolic reprogramming drives the development of an immunosuppressive tumor microenvironment (TME) through various pathways, contributing to cancer progression and reducing the effectiveness of anticancer immunotherapy. However, our understanding of the metabolic landscape within the tumor-immune context has been limited by conventional metabolic measurements, which have not provided comprehensive insights into the spatiotemporal heterogeneity of metabolism within TME. The emergence of single-cell, spatial, and in vivo metabolomic technologies has now enabled detailed and unbiased analysis, revealing unprecedented spatiotemporal heterogeneity that is particularly valuable in the field of cancer immunology. This review summarizes the methodologies of metabolomics and metabolic regulomics that can be applied to the study of cancer-immunity across single-cell, spatial, and in vivo dimensions, and systematically assesses their benefits and limitations.
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.
Xie X, Liu W, Yuan Z, Chen H, Mao W Mol Cancer. 2025; 24(1):71.
PMID: 40057791 PMC: 11889836. DOI: 10.1186/s12943-025-02269-y.
From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.
Xu X, Su J, Zhu R, Li K, Zhao X, Fan J Mol Cancer. 2025; 24(1):63.
PMID: 40033282 PMC: 11874780. DOI: 10.1186/s12943-025-02240-x.
Copper in melanoma: At the crossroad of protumorigenic and anticancer roles.
Chrzan N, Hartman M Redox Biol. 2025; 81:103552.
PMID: 39970778 PMC: 11880738. DOI: 10.1016/j.redox.2025.103552.
Tang X, Zhuang H, Yu H Sci Rep. 2024; 14(1):30205.
PMID: 39632975 PMC: 11618345. DOI: 10.1038/s41598-024-81591-9.